ERBB2 and breast cancer: Patients with HER2-positive BC are more likely to experience recurrence and metastasis, especially brain metastasis, leading to poor survival outcomes (Oliveira et al., 2020; Olga Mart  ́ınez-S  ́aez and Aleix Prat, 2021).